126 related articles for article (PubMed ID: 12918521)
21. Sunitinib for imatinib-resistant GIST.
Joensuu H
Lancet; 2006 Oct; 368(9544):1303-4. PubMed ID: 17046443
[No Abstract] [Full Text] [Related]
22. [New therapeutic targets and strategies in lung cancer].
Sánchez De Cos Escuín J
Arch Bronconeumol; 2002 Aug; 38(8):386-91. PubMed ID: 12199921
[No Abstract] [Full Text] [Related]
23. Complete cytogenietic remission with imatinib mesylate treatment in chronic myelogenous leukemia (CML) developed after renal transplantation.
Koca E; Cetiner D; Goker H; Aksu S; Ozcebe OI; Haznedaroglu IC; Turgan C
Clin Nephrol; 2005 Oct; 64(4):324-6. PubMed ID: 16240908
[No Abstract] [Full Text] [Related]
24. The role of the tyrosine kinase inhibitor STI571 in the treatment of cancer.
O'Dwyer ME; Druker BJ
Curr Cancer Drug Targets; 2001 May; 1(1):49-57. PubMed ID: 12188891
[TBL] [Abstract][Full Text] [Related]
25. Complete cytogenetic and molecular response to treatment with imatinib mesylate for philadelphia chromosome positive acute myeloid leukemia with multilineage dysplasia.
Ueda K; Horiike S; Zen K; Misawa S; Taniwaki M
Leuk Lymphoma; 2006 Sep; 47(9):1967-9. PubMed ID: 17065015
[No Abstract] [Full Text] [Related]
26. Investigator profile. Brian J. Druker, M.D. Interview by Vicki P. Glaser.
Druker BJ
J Hematother Stem Cell Res; 2001 Dec; 10(6):721-4. PubMed ID: 11798498
[No Abstract] [Full Text] [Related]
27. [Molecular target therapy for malignant tumors].
Nihon Naika Gakkai Zasshi; 2005 Feb; 94 Suppl():76-80. PubMed ID: 15796061
[No Abstract] [Full Text] [Related]
28. [Targeted treatment of cancers with imatinib mesylate (STI571, Gleevec): results of Asco 2002].
Ray-Coquard I; Blay JY
Bull Cancer; 2002 Jun; 89(6):567-9. PubMed ID: 12135855
[No Abstract] [Full Text] [Related]
29. Hits and misses in targeting pediatric cancers.
Bernstein ML
Pediatr Blood Cancer; 2009 Jul; 52(7):751-2. PubMed ID: 19185009
[No Abstract] [Full Text] [Related]
30. New drugs in acute myeloid leukemia.
Grever MR
Clin Adv Hematol Oncol; 2003 Aug; 1(8):456-9. PubMed ID: 16258431
[No Abstract] [Full Text] [Related]
31. KIT and PDGF as targets.
Verweij J
Cancer Treat Res; 2004; 120():117-27. PubMed ID: 15217221
[No Abstract] [Full Text] [Related]
32. [Gastrointestinal stromal tumor (GIST)--tyrosine kinase inhibitors].
Nishida T; Yoshidome K; Tori M
Nihon Rinsho; 2012 Nov; 70 Suppl 8():452-6. PubMed ID: 23513883
[No Abstract] [Full Text] [Related]
33. [Consensus on the medical treatment of gastrointestinal stromal tumors].
Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):875-7. PubMed ID: 18396652
[No Abstract] [Full Text] [Related]
34. Myelofibrosis: biology and treatment options.
Cervantes F
Eur J Haematol Suppl; 2007 Oct; (68):13-7. PubMed ID: 17727559
[No Abstract] [Full Text] [Related]
35. Receptor tyrosine kinases as rational targets for prostate cancer treatment: platelet-derived growth factor receptor and imatinib mesylate.
George DJ
Urology; 2002 Sep; 60(3 Suppl 1):115-21; discussion 122. PubMed ID: 12231066
[TBL] [Abstract][Full Text] [Related]
36. Effect of tyrosine kinase inhibition by imatinib mesylate on mast cell tumors in dogs.
Isotani M; Ishida N; Tominaga M; Tamura K; Yagihara H; Ochi S; Kato R; Kobayashi T; Fujita M; Fujino Y; Setoguchi A; Ono K; Washizu T; Bonkobara M
J Vet Intern Med; 2008; 22(4):985-8. PubMed ID: 18564222
[TBL] [Abstract][Full Text] [Related]
37. STI571 (glivec-tm): a new paradigm for the development of innovative therapies in onco-hematology?
Gambacorti C
Tumori; 2001; 87(6):S10-2. PubMed ID: 11989608
[No Abstract] [Full Text] [Related]
38. Targeting mutant kinases in gastrointestinal stromal tumors: a paradigm for molecular therapy of other sarcomas.
Heinrich MC; Corless CL
Cancer Treat Res; 2004; 120():129-50. PubMed ID: 15217222
[No Abstract] [Full Text] [Related]
39. Role of receptor tyrosine kinases in gastric cancer: new targets for a selective therapy.
Becker JC; Muller-Tidow C; Serve H; Domschke W; Pohle T
World J Gastroenterol; 2006 Jun; 12(21):3297-305. PubMed ID: 16733844
[TBL] [Abstract][Full Text] [Related]
40. [A rare complication of imatinib mesylate therapy: drug-induced pneumonitis].
Stakhina OV; Turkina AG; Kostina IE; Kochkareva IuB
Ter Arkh; 2010; 82(2):59-61. PubMed ID: 20387680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]